Zhujiang Hospital: Carcinoma trials

The registry lists 13 Carcinoma studies with Zhujiang Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort StudyRecruitingNCT06861114
• A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or AblationNot yet recruitingNCT06546280Phase 2
• Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular CarcinomaNot yet recruitingNCT06449846
• Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCSNot yet recruitingNCT06317896
• Surgical Resection Combined With Intraperitoneal Hyperthermic ChemotherapyNot yet recruitingNCT06247293
• Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid CarcinomaRecruitingNCT04354324Not applicable
• Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world StudyStatus unknownNCT05638438
• The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular CarcinomaStatus unknownNCT03917017Not applicable
• Application of Watson for Oncology in Hepatocellular Carcinoma SurgeryStatus unknownNCT03904667
• The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular CarcinomaStatus unknownNCT03793322Phase 1
• Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical CancerStatus unknownNCT03469531Phase 2
• To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid TumorsCompletedNCT03159585Phase 1
• Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic CarcinomaStatus unknownNCT03132740